PepGen Inc. (PEPG)
NASDAQ: PEPG · Real-Time Price · USD
5.44
+0.13 (2.45%)
At close: Dec 5, 2025, 4:00 PM EST
5.41
-0.03 (-0.55%)
After-hours: Dec 5, 2025, 7:55 PM EST
PepGen Employees
PepGen had 81 employees as of December 31, 2024. The number of employees increased by 17 or 26.56% compared to the previous year.
Employees
81
Change (1Y)
17
Growth (1Y)
26.56%
Revenue / Employee
n/a
Profits / Employee
-$1,155,025
Market Cap
373.99M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 81 | 17 | 26.56% |
| Dec 31, 2023 | 64 | 19 | 42.22% |
| Dec 31, 2022 | 45 | 14 | 45.16% |
| Dec 31, 2021 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PEPG News
- 24 days ago - PepGen Announces Issuance of U.S. Patent for Proprietary PGN-EDODM1 Molecule - Business Wire
- 24 days ago - PepGen Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights - Business Wire
- 4 weeks ago - PepGen to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - PepGen: DMD Discontinued, Ways To Go With DM1 - Seeking Alpha
- 2 months ago - PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle Society - Business Wire
- 2 months ago - PepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares - Business Wire
- 2 months ago - PepGen Reports Highest Splicing Correction In Dystrophy Patients, Stock Doubles - Benzinga
- 2 months ago - PepGen Announces Pricing of $100 Million Public Offering - Business Wire